Halozyme Therapeutics Shares Down 29.9% Since SmarTrend's Sell Call (HALO)
January 26, 2016 at 14:06 PM EST
SmarTrend identified a Downtrend for Halozyme Therapeutics (NASDAQ:HALO) on January 11th, 2016 at $13.39. In approximately 2 weeks, Halozyme Therapeutics has returned 29.92% as of today's recent price of...
